According to Neogen's latest financial reports the company's current EPS (TTM) is -$0.12. In 2022 the company made an earnings per share (EPS) of $0.04876 a decrease over its 2021 EPS that were of $0.54.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.12 | -344.86% |
2022 | $0.04876 | -90.91% |
2021 | $0.54 | -5.49% |
2020 | $0.57 | -0.6% |
2019 | $0.57 | -9.46% |
2018 | $0.63 | 24.57% |
2017 | $0.51 | 29.93% |
2016 | $0.39 | 10.06% |
2015 | $0.35 | 12.93% |
2014 | $0.31 | 9.27% |
2013 | $0.29 | 9.91% |
2012 | $0.26 | 10.82% |
2011 | $0.24 | 4.94% |
2010 | $0.22 | 31.63% |
2009 | $0.17 | 10.06% |
2008 | $0.16 | 23.45% |
2007 | $0.13 | 24.18% |
2006 | $0.10 | 32.85% |
2005 | $0.07611 | -1.25% |
2004 | $0.07708 | 3.03% |
2003 | $0.07481 | 12.21% |
2002 | $0.06667 | 22.95% |
2001 | $0.05422 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $15.34 | -12,946.82% | ๐บ๐ธ USA |
Becton Dickinson BDX | $5.55 | -4,747.97% | ๐บ๐ธ USA |
IDEXX Laboratories IDXX | $9.91 | -8,399.35% | ๐บ๐ธ USA |
Illumina ILMN | -$26.61 | 22,185.13% | ๐บ๐ธ USA |
Danaher DHR | $8.02 | -6,816.52% | ๐บ๐ธ USA |
PerkinElmer
PKI | $7.70 | -6,548.36% | ๐บ๐ธ USA |
Pacific Biosciences
PACB | -$1.27 | 963.59% | ๐บ๐ธ USA |
Meridian Bioscience VIVO | $0.97 | -912.35% | ๐บ๐ธ USA |